Lexology September 16, 2024
Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and services. According to Getinge’s press release, the total purchase price was $477 million.
According to its press release, Getinge paid approximately USD 253 million in cash upon completion of the acquisition, on a cash and debt free basis. Getinge plans to pay earn-out payments between 2024 and 2026 if agreed upon regulatory and financial performance milestones are achieved. The earn-out payments may exceed USD 224 million in aggregate.
According to Getinge, the total market for transplants has been growing rapidly in recent years and is expected to continue to experience double digit...
Today's Sponsors
Today's Sponsor